|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1341 G Street NW |
Address2 | Suite 1100 |
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 320918-12
|
||||||||
|
6. House ID# 395540000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lisa Kountoupes, President |
Date | 01/13/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1321 & S. 2404, Medicare Advanced Laboratory Diagnostics Act of 2007; H.R. 5765, Medicare Remote Monitoring Access Act of 2008; S. 631 Remote Monitoring Act of 2007; S. 2221, Transparency in Medical Device Pricing Act of 2007;
H.R. 6331, Medicare Improvements for Patients & Providers Act of 2008; H.R. 3162, Childrens Health & Medicare Protection Act of 2007; S. 2029, Physician Payment Sunshine Act; H.R. 3023, Drug & Medical Device Company Gift Disclosure Act
S. 1893, Children's Health Insurance Program Reauthorization Act of 2007; Legislation addressing Comparative Effectiveness including S. 3408, Comparative Effectiveness Research Act of 2008
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lisa |
Kountoupes |
|
Deputy Asst. to the President & House Liaison |
|
Lisa |
Kountoupes |
|
Special Asst. to the President for Leg. Affiars |
|
Lisa |
Kountoupes |
|
Asst. Director for Legislative Affairs at OMB |
|
Lisa |
Kountoupes |
|
Special Asst. to Undersecretary, Dept. of Energy |
|
Lisa |
Kountoupes |
|
Policy Adv. to Chmn., Energy & Commerce Comm |
|
Julie Hershey |
Carr |
|
LA, LA & Sr. Policy Advisor, Rep. Joe Pitts R-PA |
|
Lori |
Denham |
|
Chief of Staff, LD & Sr. Policy Advisor to Rep. |
|
Lori |
Denham |
|
Cal Dooley D-CA |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
House Discussion Draft of the Food and Drug Administration Globalization Act;
Senate Draft Legislation regarding inspections of medical device manufacturing facilities;
H.R. 6381& S. 3398, to Amend the Federal Food, Drug and Cosmetic Act with respect to liability under state and local requirements respecting devices and other related proposals; House and Senate proposals on comprehensive health care reform
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lisa |
Kountoupes |
|
Deputy Asst. to the President & House Liaison |
|
Lisa |
Kountoupes |
|
Special Asst. to the President for Leg. Affairs |
|
Lisa |
Kountoupes |
|
Assistant Director for Legislative Affairs at OMB |
|
Lisa |
Kountoupes |
|
Special Asst. to Undersecretary, Dept. of Energy |
|
Lisa |
Kountoupes |
|
Policy Advisor to Chmn. Energy & Commerce Com |
|
Julie Hershey |
Carr |
|
LA, LD & Sr. Policy Advisor, Rep. Joe Pitts R-PA |
|
Lori |
Denham |
|
Chief of Staff, LD & Senior Policy Advisor to Rep. |
|
Lori |
Denham |
|
Cal Dooley D-CA |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |